Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Completed 3Terminated 1

Sponsor Class

OTHER 1NETWORK 1INDUSTRY 1

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Gastrointestinal 1Breast 1

Conditions

Osteoporosis 1Hematologic Neoplasms 1Esophageal Neoplasms 1Carcinoma, Squamous Cell 1Breast Neoplasms 1Bone Diseases, Metabolic 1Adenocarcinoma 1

Interventions

Cyclophosphamide 641Bevacizumab 552Paclitaxel 534Carboplatin 533Cisplatin 480pembrolizumab 456Gemcitabine 422Docetaxel 415Rituximab 386Radiotherapy 373Dexamethasone 351Doxorubicin 330Nivolumab 308Fluorouracil 286Capecitabine 260Etoposide 245Prednisone 244Oxaliplatin 242Erlotinib Hydrochloride 242Cytarabine 233Lenalidomide 232Trastuzumab 226Pemetrexed 220Vincristine 212fludarabine phosphate 208Leucovorin 208Cetuximab 208Filgrastim 204Bortezomib 193Methotrexate 183

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Has results × Ibandronic Acid × Clear all
NCT01077817 2022-02-03

Observational Study of Incidence Rates of Esophageal Cancer in Women Taking Medications for the Prevention or Treatment of Osteoporosis (MK-0217A-352)

Organon and Co

Completed
684,815 enrolled 6 charts
Gastrointestinal

Adenocarcinoma, Carcinoma, Squamous Cell, Esophageal Neoplasms

NCT00127205 2021-07-02

S0307 Phase III Trial of Bisphosphonates as Adjuvant Therapy for Primary Breast Cancer.

SWOG Cancer Research Network

Phase 3 Completed
6,097 enrolled 20 charts
Breast

Breast Neoplasms

NCT00824993 2018-09-13

Prevention of Osteoporosis in Bone Marrow Transplantation (BMT) Patients

M.D. Anderson Cancer Center

Phase 3 Completed
78 enrolled 7 charts
Other hematologic neoplasm

Bone Diseases, Metabolic, Osteoporosis, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡